Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT00315757

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Scripps Clinic Medical Group, Inc. La Jolla, California, United States
  • Cancer and Blood Disorders Center Lecanto, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression

NCT00480363

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Hospital germans Trias i Pujol Badalona, Spain
  • Hospital Clínic i Provincial de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital del SAS de Jerez de la Frontera Jerez de la Frontera, Spain
View all 13 locations
View Trial Details
Completed

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

NCT01708564

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UC Davis Health System Internal Medicine: Hematology & Oncology Sacramento, California, United States
  • RUSH Hemophilia & Thrombophilia Center Chicago, Illinois, United States
  • Centre for Human Drug Research Leiden, Netherlands
View Trial Details
Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

NCT00723359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details

Related conditions